BACKGROUND
We are a blank check company formed in Delaware on January 7, 2022, for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar initial business combination with one or more businesses or entities.
On the Record Date, there were 13,149,600 shares of common stock outstanding and entitled to vote, of which 10,648,350 are Class A Common Stock and 2,501,250 are Class B Common Stock. In addition, we issued (i) 10,005,000 units as part of our IPO, and (ii) an aggregate of 543,000 Private Units issued to our Sponsor in a private placement simultaneously with the consummation of our IPO. As of March 31, 2023, there were 10,005,000 public warrants outstanding. As of March 31, 2023 there were 543,000 Private Units outstanding.
Each whole warrant entitles its holder to purchase one whole share of Class A Common Stock at an exercise price of $11.50 per share. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination and 12 months from the closing of our IPO and expire five years after the completion of our initial business combination or earlier upon redemption or liquidation. We have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the reported last sale price of our Class A Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading-day period commencing once the warrants become exercisable and ending on the third trading day prior to the date on which we give proper notice of such redemption and provided certain other conditions are met.
A total of approximately $100,050,000 of the proceeds from our IPO and the simultaneous sale of the Private Units in a private placement transaction was placed in our Trust Account in the United States maintained by Continental, acting as trustee, invested in U.S. “government securities,” within the meaning of Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open ended investment company that holds itself out as a money market fund selected by us meeting the conditions of Rule 2a-7 of the Investment Company Act, until the earlier of: (i) the consummation of a business combination or (ii) the distribution of the proceeds in the Trust Account as described below.
Approximately $106,126,507.41 was held in the Trust Account as of the Record Date. The mailing address of the Company’s principal executive office is 850 Liberty Avenue, Suite 204, Newark, Delaware 19711.
Business Combination
The purpose of the Charter Amendment Proposal, and, if necessary, the Adjournment Proposal, is to allow us additional time to complete the Business Combination. The Company’s IPO prospectus and the Existing Charter provide that the Company has until the Termination Date to complete a Business Combination.
On March 13, 2023, we entered into an agreement and plan of merger (the "Merger Agreement") with SRIVARU Holding Limited, a Cayman Islands exempted company ("SVH") and Pegasus Merger Sub Inc., a Delaware corporation, and a direct, wholly owned subsidiary of SVH ("Merger Sub"). Pursuant to the terms of the Merger Agreement, a business combination between the Company and SVH will be effected through the merger of Merger Sub with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of SVH (the "Merger").
While we are using our best efforts to enter into and complete the Merger as soon as practicable, our board of directors (the “Board”) believes that there will not be sufficient time before the Termination Date to hold a general meeting at which to conduct a vote for stockholder approval of the Merger. Accordingly, the Board believes that in order to be able to consummate the Merger, we will need to obtain the Extension. Without the Extension, the Board believes that there is significant risk that we might not, despite our best efforts, be able
18